Table 2.

Baseline and follow-up biochemistry analyses.

Patient #	Visit	HbA1ca (%)	Change from baseline	FPGb (mmol/l)	Change from baseline	TGc (mmol/l)	Change from baseline
1	Baseline	7.6		8.1		1.5
	Week 8	6.3	−1.3	5.5	−2.6	1.6	0.1
	Week 16	6.2	−1.4	3.5	−4.6	1.8	0.3
3	Baseline	9.7		18.5		1.7
	Week 8	5.2	−4.5	5.6	−12.9	1.2	−0.5
	Week 16	5.1	−4.6	4.6	−13.9	1.5	−0.2
4	Baseline	9.1		10.7		2.3
	Week 8	8.2	−0.9	7.6	−3.1	1.8	−0.5
	Week 16
8	Baseline	10.4		8.8		3
	Week 8
	Week 16	6.1	−4.3	3.8	−5	1.7	−1.3
11	Baseline	9.4		5.7		0.9
	Week 8	10.2	0.8	5.2	−0.5	0.9	0
	Week 16
12	Baseline	9.2		13.5		1.6
	Week 8	8.2	−1	12.3	−1.2	2.5	0.9
	Week 16
14	Baseline	8.8		8		2
	Week 8	7.7	−1.1	2.7	−5.3	2.2	0.2
	Week 16
Average (SD) (week 8)	n	6		6		6
	Baseline	9.0 (0.7)		10.8 (4.6)		1.7 (0.5)
	Week 8	7.6 (1.6)	−1.3 (1.6)	6.5 (3.0)	−4.3 (4.2)	1.7 (0.6)	0.0 (0.5)
Average (SD) (week 16)	n	3		3		3
	Baseline	9.2 (1.5)		11.8 (5.8)		2.1 (0.8)
	Week 16	5.8 (0.6)	−3.4 (1.6)	4.0 (0.6)	−7.8 (5.3)	1.7 (0.2)	−0.4 (0.8)

^aHbA1c: hemoglobin A1c.

^bFPG: fasting plasma glucose.

^cTG: triglycerides.

^dSD: standard deviation.